Aurinia Pharmaceuticals Inc. appointed Jeffry Randall to its board of directors and named him chairman of the audit committee.
Victoria, British Columbia-based Aurinia is a clinical stage biopharmaceutical company focused on the immunology market.
Discover more about S&P Global’s offerings